Related Experiment Video
Updated: Apr 15, 2026

Adult Zebrafish Injury Models to Study the Effects of Prednisolone in Regenerating Bone Tissue
Published on: October 18, 2018
[The ROS-generating and antioxidant systems in the liver of rats treated with prednisolone and vitamin D3]
Abstract:
The mechanisms of glucocorticoid-induced disturbances of liver function is currently not fully clarified. Vitamin D3 was previously shown to play an important role in the regulation of impaired oxidative metabolism and detoxification function of the liver associated with the effects of hepatotoxic compounds. The study was undertaken to define the intensity of oxidative metabolism in the rat liver and survival of hepatocytes after prolonged prednisolone administration and to assess whether vitamin D3 is capable to counter glucocorticoid-induced changes. It has been shown that prednisolone (0.5 mg per animal for 30 days) leads to 1.6-fold increase in the percentage of necrotic cells among isolated hepatocytes as compared with the control. The glucocorticoid-induced impairment of hepatocellular function was accompanied by enhanced generation of reactive oxygen species (ROS), accumulation of TBA-active products and carbonylated proteins but reduced levels of free SH-groups of low molecular weight compounds. It was demonstrated a decrease in the activities of key enzymes of antioxidant system (SOD, catalase, glutathione peroxidase), whereas the activities of pro-oxidant enzymes NAD(P)H-quinone oxidoreductase and semicarbazide-sensitive amine oxidase were shown to be increased. Vitamin D3 (and to greater extent in combination with α-tocopherol) administration (100 IU) on the background of glucocorticoid therapy caused normalizing effects on the level of ROS formation, oxidative modification of biomolecules and activity of antioxidant enzymes resulting in better survival of hepatocytes. These data suggest a potential role of vitamin D3 in the regulation of oxidative metabolism alterations related to hepatotoxic action of glucocorticoids.
Insights
Vitamin D3 may protect the liver from glucocorticoid damage by reducing oxidative stress and improving antioxidant enzyme activity. This finding offers potential therapeutic strategies for managing drug-induced liver injury.
Area of Science:
- Hepatology
- Endocrinology
- Biochemistry
Context:
- Glucocorticoids, like prednisolone, can cause liver dysfunction through mechanisms not fully understood.
- Oxidative stress and impaired detoxification are implicated in drug-induced liver injury.
- Vitamin D3 has shown potential in regulating oxidative metabolism and liver detoxification.
Purpose:
- To investigate the effects of prolonged prednisolone administration on rat liver oxidative metabolism and hepatocyte survival.
- To determine if Vitamin D3 can counteract prednisolone-induced liver damage.
- To assess the combined effect of Vitamin D3 and alpha-tocopherol against glucocorticoid-induced liver injury.
Summary:
- Prednisolone treatment increased hepatocyte necrosis and oxidative stress markers, including reactive oxygen species (ROS) and lipid peroxidation.
- Glucocorticoid therapy decreased antioxidant enzyme activity (SOD, catalase, glutathione peroxidase) while increasing pro-oxidant enzyme activity.
- Vitamin D3, particularly with alpha-tocopherol, normalized ROS levels, reduced oxidative damage to biomolecules, and improved antioxidant enzyme function, enhancing hepatocyte survival.
Impact:
- These findings highlight Vitamin D3's potential role in mitigating glucocorticoid-induced hepatotoxicity.
- The study suggests Vitamin D3 as a potential therapeutic agent to protect liver function during glucocorticoid therapy.
- Understanding Vitamin D3's protective mechanisms can inform future strategies for preventing and treating drug-induced liver injury.

